Leap Therapeutics Inc
LPTX
Market Cap$12.08M
Close$
$1.25
340.9% upside
Current Fair Value
340.9% upsideUndervalued by 340.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.08 Million |
|---|---|
| Enterprise Value | $-13,054,530.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.81 |
| Beta | -0.22 |
| Outstanding Shares | 41,268,894 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.17 |
|---|---|
| PEG | -1.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.18 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.58 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
ESG Score
No data